SEC Form 4 · accession 0001415889-15-001832
Echo Therapeutics, Inc. · ECTE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Scott Wayne Hollander
Officer — PRESIDENT AND CEO · Director
Period of report
May 20, 2015
Accepted (ET)
May 20, 2015 · 4:28 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001031927
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 20, 2015 | P | 8,000 | $1.48 | A | 8,000 | D |
Table II — derivative securities
No Table II lines on this filing.